{{Short description|American author and businessman (born 1954)}} {{for|the United States Navy aviator|James B. Linder}} {{Infobox officeholder | name = James Linder | image = | caption = | office = Interim President of the University of Nebraska system | term_start = June 1, 2014 | term_end = April 12, 2015 | predecessor = James Milliken | successor = Hank Bounds | birth_date = {{birth date and age|1954|10|21}} | birth_place = Omaha, Nebraska, U.S. | occupation = Advisor, former CEO of Nebraska Medicine<br />Professor Emeritus <!--| title = Professor Emeritus--> | spouse = Karen Linder <!--| discipline = Pathology--> | website = {{URL|https://www.unmc.edu/pathology/faculty/bios/linder.html|unmc.edu}} | education = Iowa State University<br/>Duke University | alma_mater = University of Nebraska Medical Center }} '''James Linder''' (born 1954) is an American author, academic and businessperson, as well as an authority on university research commercialization.<ref>{{Cite web |url=http://www.aahcdc.org/files/agenda_vp_07.pdf |title=Association of Academic Health Centers, technology transfer conference, June 14, 2007 |access-date=June 28, 2007 |archive-date=August 9, 2018 |archive-url=https://web.archive.org/web/20180809152859/http://www.aahcdc.org/files/agenda_vp_07.pdf |url-status=dead }}</ref> He is an advisor to Nebraska Medicine, following his tenure as its chief executive officer (CEO) and board chair.<ref name=Nmed/><ref>[https://www.omaha.com/livewellnebraska/nebraska-medicine-replaces-ceo-picks-new-leader-familiar-in-state/article_d80db4d6-bc32-5059-8288-e735a239a7ca.html Omaha World Herald August 8, 2018]</ref> Formerly, he was president of the University Technology Development Corporation and chief strategist for the University of Nebraska system.<ref>[http://nebraska.edu/technology-developers.html University of Nebraska website]</ref> He is also a professor of pathology and microbiology at the University of Nebraska Medical Center.
==Early life and education== A native to Omaha, Linder earned his B.S. degree in biochemistry and microbiology from Iowa State University in 1976,<ref name=UNMC>{{cite web|url=https://www.unmc.edu/pathology/faculty/bios/linder.html|title=James Linder, MD|website=unmc.edu|publisher=University of Nebraska Medical Center}}</ref> and his M.D. degree, with distinction, from the University of Nebraska Medical Center (UNMC) in 1980.<ref name=UNMC/> He completed his residency training in pathology at Duke University Medical Center and UNMC.
==Academic activities== Linder was interim president of the University of Nebraska system from May 2014 until April 2015.<ref>[http://journalstar.com/news/state-and-regional/nebraska/regents-approve-linder-as-interim-nu-president/article_638bf183-dd94-5dac-bfee-505c853ca974.html Lincoln Journal Star, March 21, 2014]</ref> He has been on the UNMC faculty since 1983 when he joined the Pathology and Microbiology department. In 1986 he was named associate professor and in 1989 was named professor. He has held numerous administrative positions at UNMC, including vice chairman of Pathology and Microbiology, director of Surgical Pathology, director of Cytopathology, associate dean for Academic Affairs and interim dean of Medicine. He was associate vice chancellor for Research from 2005-2009, and was responsible for developing clinical research and intellectual property programs at UNMC.<ref>[http://app1.unmc.edu/PublicAffairs/newsarchive/view_art.cfm?article_id=1179 UNeMed news release, September 6, 2005]</ref> He was visiting professor at the Peter Kiewit Institute. In January 2007, UNMC's intellectual property office merged with UNeMed, and Linder was appointed president of the expanded operation.<ref>{{Cite web |url=http://www.unmc.edu/newunemed/index2.php?option=com_content&do_pdf=1&id=46 |title=UNMC news, January 9, 2007 |access-date=June 28, 2007 |archive-date=September 30, 2007 |archive-url=https://web.archive.org/web/20070930194232/http://www.unmc.edu/newunemed/index2.php?option=com_content&do_pdf=1&id=46 |url-status=dead }}</ref>
He is a former president of the American Society for Clinical Pathology.<ref name="ascp.org">{{Cite web |url=http://www.ascp.org/AboutUs/newsroom/pdf/July_05_WEB.pdf |title=''Pathology Today'', July 2005, page 8 |access-date=2007-06-28 |archive-date=2007-09-26 |archive-url=https://web.archive.org/web/20070926235823/http://www.ascp.org/AboutUs/newsroom/pdf/July_05_WEB.pdf |url-status=dead }}</ref> He is a frequent guest lecturer, and has written five textbooks and more than 130 professional articles.<ref>[http://www.experts.scival.com/nebraska/expertPubs.asp?n=James+Linder&u_id=1765 UNMC website, list of Dr. J. Linder publications]</ref> He is on several editorial boards, including the ''American Journal of Clinical Pathology''<ref>[http://www.ajcp.com/editorialboard.aspx ''American Journal of Clinical Pathology'', editorial board]</ref> and ''Modern Pathology''.<ref>[http://www.nature.com/modpathol/about.html ''Modern Pathology'', editorial board]</ref> He is a member and has had leadership positions with many medical organizations, and active in the development of the Interactive Center of the U.S.-Canadian division of the International Academy of Pathology.<ref>[http://www.uscap.org/interactive USCAP Linder Learning Center]</ref>
He holds numerous patents, and his academic interests include the application of technology in medical diagnostics, including immunochemistry, molecular diagnostics, computer-aided instruction, digital imaging in pathology, and the use of automated techniques in cytopathology and hematology.
==Business activities== From 1995 to 2007 he was medical director of Cytyc Corporation, a company based in Marlborough, Mass. dedicated to women's health.<ref>{{Cite web |url=http://ir.cytyc.com/ReleaseDetail.cfm?ReleaseID=175153 |title=Cytyc Corp., news release, September 29, 2005 |access-date=June 28, 2007 |archive-url=https://web.archive.org/web/20070813233731/http://ir.cytyc.com/ReleaseDetail.cfm?ReleaseID=175153 |archive-date=August 13, 2007 |url-status=dead }}</ref> A main area of interest was improving Pap testing.
From 2009 to 2013, he was founding chief medical officer for Constitution Medical Investors. The company was later acquired by the Roche Diagnostics,<ref>{{Cite web |url=http://www.roche.com/media/media_releases/med-cor-2013-07-02.htm |title=Roche Press Release |access-date=2014-02-17 |archive-date=2014-07-06 |archive-url=https://web.archive.org/web/20140706142239/http://www.roche.com/media/media_releases/med-cor-2013-07-02.htm |url-status=dead }}</ref> in 2013, and Linder stayed on, until 2015, as Chief Medical Officer, and developed a hematology analyzer.<ref>[http://bloodhoundcbc.com/ Roche Diagnostics Hematology website]</ref> Linder and his wife, Karen Linder, are founders and managing directors of Linseed Capital, LLC, which invests in early-stage companies,<ref>[http://linseedcapital.wordpress.com/ Linseed Capital website]</ref> and of Tethon3D, which develops materials for ceramic 3D printing.<ref>{{Cite web |date=2017-04-18 |title=Tethon 3D |url=https://manufacturing-today.com/news/tethon-3d/ |access-date=2025-07-28 |website=Manufacturing Today }}</ref>
In July 2025, Linder stepped down as CEO and chairman, becoming a special advisor to the Nebraska Medicine board.<ref name=Nmed>{{Cite web |date=2025-07-01 |title=Lance Fritz named chair of Nebraska Medicine Board of Directors |url=https://www.nebraskamed.com/health/nebraska-medicine-news/lance-fritz-named-chair-of-nebraska-medicine-board-of-directors |access-date=2025-07-04 |website=www.nebraskamed.com |language=en}}</ref>
He previously chaired the board of Nobl Health, a company which provides nursing-management software,<ref>[http://noblhealth.com/ Nobl Health website]</ref> and also chaired the scientific advisory board of Streck Corporation, a manufacturer of clinical laboratory products.<ref>[http://www.streck.com/ Streck Corporation website]</ref>
==Awards and honors== Linder has been accorded several professional honors and awards. In 2015, recognizing accomplishments in laboratory medicine and technology transfer, he was inducted as a fellow of the National Academy of Inventors.<ref>[http://www.prnewswire.com/news-releases/national-academy-of-inventors-names-170-new-fellows-300010066.html National Academy 2015 Inductees]</ref> In 2014 he and Karen Linder received the Entrepreneurial Leadership Award.<ref>[https://web.archive.org/web/20140222064024/http://www.nebraskaentrepreneurship.com/news/pipeline-announces-innovator-of-the-year-and-new-fellows/ Nebraska Entrepreneurship news release]</ref> In 2013 Linseed Capital was recognized as Investor of the Year by the Silicon Prairie News.<ref>[http://www.siliconprairienews.com/2013/08/and-the-12-winners-of-the-2013-silicon-prairie-awards-are Silicon Prairie News]</ref> In 2005, he was presented with the American Society of Clinical Pathologists' "Israel Davidsohn Award for Distinguished Service."<ref name=UNMC/> He received the Iowa State University Distinguished Alumni Award, in 2020,<ref>{{cite web|url=https://www.isualum.org/s/565/17/interior.aspx?pgid=2506&gid=1|title=DISTINGUISHED ALUMNI AWARD 2020|website=isualum.org|publisher=Iowa State university}}</ref> and he and Karen Linder were inducted into the Omaha Business Hall of Fame.<ref>{{cite web|url=https://www.omahachamber.org/omaha-business-hall-of-fame-welcomes-2020-inductees/|title=Omaha Business Hall of Fame Welcomes 2020 Inductees|website=omahachamber.org|publisher=Greater Omaha Chamber of commerce}}</ref>
==Boards and community service== Linder is the former chairman of the Nebraska Medicine board of directors.<ref>{{Cite web |title=Dr. James Linder to replace Dr. Gold on Nebraska Medicine board |url=https://nebraskaexaminer.com/briefs/dr-james-linder-to-replace-dr-gold-on-nebraska-medicine-board/ |access-date=2025-07-28 |website=Nebraska Examiner}}</ref>
From 1999-2001, he was on the board of directors of the Omaha Children's Museum. He was chairman of the board of KANEKO, an organization devoted to fostering creativity, and is chair of the Kaneko Creative Council.<ref>[http://www.thekaneko.org/ KANEKO Open Space for your mind, Omaha]</ref> He was a regional board member of the Pipeline Entrepreneurship Program.<ref>{{Cite web |url=http://www.omaha.com/article/20130120/MONEY/701209905 |title=''Omaha World Herald'', January 20, 2013 |access-date=January 28, 2013 |archive-date=February 16, 2013 |archive-url=https://archive.today/20130216151031/http://www.omaha.com/article/20130120/MONEY/701209905 |url-status=dead }}</ref> He is a trustee the Committee for Economic Development of the Conference Board and a member of the CNBC CEO Council.<ref>{{Cite web |title=CEO Council |url=https://www.cnbccouncils.com/ceo-council/ |access-date=2025-07-28 |website=CNBC Councils |language=en-US}}</ref>
==Personal and family== Linder is married to Karen Linder SCT(ASCP), president of Tethon 3D<ref>[http://tethon3d.com/ Tethon3D website]</ref><ref name=FPBCC>{{Cite web |date=February 2019 |title=LEADERSHIP PROFILE Director of the Fred & Pamela Buffett Cancer Center |url=https://www.unmc.edu/aboutus/leadership-mission/search/FPBCCdirector.pdf |access-date=2025-07-28 |website=University of Nebraska Medical Center |page=13}}</ref> and author of ''The Women of Berkshire Hathaway''.<ref>[http://womenofberkshire.wordpress.com/author/curlyjack/ ''Women of Berkshire Hathaway'']</ref> They have five children.<ref name=FPBCC/>
==References== {{reflist}}
{{s-start}} {{succession box | before=Dr. Philip Barney, M.D. | title=President of American Society for Clinical Pathology | years=1998–1999 | after=Dr. Stebbins Chandor, M.D. }} {{s-end}}
{{Authority control}} {{University of Nebraska System presidents}}
{{DEFAULTSORT:Linder, James}} Category:Living people Category:University of Nebraska Medical Center alumni Category:Iowa State University alumni Category:American pathologists Category:University of Nebraska Medical Center faculty Category:1954 births Category:Presidents of the University of Nebraska system